Finance

Beta
Lists
BDSX:NASDAQ
Biodesix Inc
$24.50
+8.65%
(+1.95) 1D
$24.50
0.00% (0.00)
After hours
Closed: Jul 1, 3:58:55 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for BDSX...
Open
$22.74
High
$24.92
Low
$21.88
Mkt. cap
256.82M
Avg. vol.
71.35K
Volume
112.50K
52-wk high
$24.92
52-wk low
$5.26
EPS
-$4.03
Beta
0.59
Shares outstanding
10.36M
No. of employees
334
Open
$22.74
High
$24.92
Low
$21.88
Mkt. cap
256.82M
Avg. vol.
71.35K
Volume
112.50K
52-wk high
$24.92
52-wk low
$5.26
EPS
-$4.03
Beta
0.59
Shares outstanding
10.36M
No. of employees
334
News stories
From sources across the web
About Biodesix Inc
CEO-
Employees334
Founded2005
HeadquartersLouisville, Colorado, United States
SectorHealth care provider
Analyst ratings
Based on 7 analysts giving stock ratings to BDSX in the past 3 months
Strong buy
Buy
7
Hold
0
Sell
0
12-month forecast
Based on 7 Wall Street analysts offering 12 month price targets for BDSX in the last 3 months.
Highest
Current $24.50
$40.00 (+63.27%)
Average
$31.00 (+26.53%)
Lowest
$26.00 (+6.12%)
Analyst
Recommendation
Action
Price target
Projected
Date
Max Masucci
Roth MKM
Buy
Initiated
$32.00
+30.6%
06/25/2026
Unknown Analyst
Roth MKM
Buy
Initiated
$32.00
+30.6%
06/24/2026
Kyle Mikson CFA
Canaccord Genuity
Buy
Reiterated
$27.00
+10.2%
06/18/2026
Yi Chen
H.C. Wainwright
Buy
Initiated
$26.00
+6.1%
06/15/2026
Daniel Brennan
TD Cowen
Buy
Reiterated
$30.00
+22.4%
05/05/2026
William Bonello
Craig-Hallum
Buy
Maintained
-
-
05/05/2026
Thomas Flaten
Lake Street
Buy
Maintained
$40.00
+63.3%
05/05/2026
Andrew Brackmann
William Blair
Buy
Maintained
-
-
05/05/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
20.02M
21.77M
28.76M
25.56M
Cost of goods sold
4.03M
4.11M
4.88M
4.60M
Cost of revenue
4.03M
4.11M
4.88M
4.60M
Research and development expenses
3.27M
2.99M
2.87M
3.28M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
22.41M
21.71M
22.97M
24.26M
Operating expense
25.68M
24.71M
25.84M
27.55M
Total operating expenses
29.71M
28.81M
30.72M
32.15M
Operating income
-9.69M
-7.04M
-1.97M
-6.60M
Other non operating income
149.00K
409.00K
46.00K
385.00K
EBT including unusual items
-11.47M
-8.72M
-3.98M
-7.79M
EBT excluding unusual items
-11.44M
-8.71M
-3.98M
-8.19M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-11.47M
-8.72M
-3.98M
-7.79M
Net profit margin
-57.29%
-40.04%
-13.84%
-30.50%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-1.90M
-2.07M
-2.06M
-1.98M
Net interest expenses
-1.90M
-2.07M
-2.06M
-1.98M
Depreciation and amortization charges
-
-
-
-
EBITDA
-8.26M
-5.64M
-579.00K
-5.20M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Deep Search
AI content may include mistakes. Learn more